Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond to traditional medications.

According to a new study, ketamine use has risen significantly since 2015. The results highlight the need for closer monitoring of recreational ketamine use.

Participants in clinic trial went from being unable to get out of bed to being productive and interacting with loved ones ...

“Ketamine is perhaps the most hopeful new psychiatric treatment to appear in the last decade, often bringing people out of severe depression or suicidality within 24-48 hours.” Quite a magic bulle ...

In a groundbreaking Interview, Professor Raz Yirmiya discusses his innovative research at the intersection of inflammation ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

New research on the most effective treatments ... Experts believe that such biomarkers can be used to guide treatment. Depression and anxiety after stroke often co-occur alongside cognitive ...

A groundbreaking depression treatment co-pioneered by Queensland researchers using a new form of brain stimulation will begin ...

Assoc Prof Cocchi said the new treatment was the result of decades ... brain networks that link to the severity of symptoms of depression, and help us to develop a personalised approach so we ...